Influence
September 9, 2021

Regenstrief research scientist: Possibility of COVID, flu “twindemic” very real

Regenstrief Institute Director of Public Health Informatics Brian Dixon, PhD, MPA, is one of many public health experts who are concerned about severe COVID-19 infections stacking on top of regular flu hospitalizations.  

“The possibility of a ‘twindemic’ is very real, especially this year,” he said. Last year there were very few flu cases, but experts attribute that to mask mandates, social distancing and other restrictions. The situation is much different this year. Dr. Dixon believes the U.S. will have at least a normal flu season, if not a bad one.  

“With our hospital system already overburdened from COVID-19, there is a real concern about flu coming in this fall, as it does every year, and putting additional strain on the healthcare system,” Dr. Dixon said. 

He and other experts are recommending people wear a mask and get vaccines for both flu and COVID-19 if they are eligible.  

 Read the Business Insider article featuring Dr. Dixon

Related News

Group photo showing all Regenstrief-affiliated participants in the 2026 AMIA Annual Symposium in Dallas, TX

Regenstrief highlighted AI and learning health systems research at AMIA 2026

Regenstrief Institute research scientists and fellows shared work on artificial intelligence, health information exchange and public health informatics at

photo of Dr. Josh Vest with New England Journal of Medicine logo

NEJM Perspective calls for screening tailored to older adults’ social needs

Regenstrief Institute and Weill Cornell Medicine researchers outline how health systems can identify unmet needs more accurately and connect

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight